Amit Khot

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 621 citations · Full text

Cutaneous T-cell Lymphoma, Lymphoid Neoplasia, Medicine +6

Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia

David Ritchie, Paul J. Neeson, Amit Khot et al. · Molecular Therapy · 2013 · 428 citations · Full text

Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation

S Kamel, Linda W. Horton, Loïc Ysebaert et al. · Leukemia · 2014 · 225 citations

Inflammation, Thrombosis, Thrombopoiesis +10

Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy

Charlotte Hughes, Amit Khot, Christopher McCormack et al. · Blood · 2014 · 223 citations

First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study

Amit Khot, Natalie Brajanovski, Donald P. Cameron et al. · Cancer Discovery · 2019 · 197 citations